Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can we predict who will benefit from neck steroid shots?

NCT ID NCT07535476

Knowledge-focused Sponsor: Mersin University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study reviewed records of 107 adults who received steroid injections in the neck for arm and neck pain caused by a pinched nerve. The goal was to find out which patient traits or injection details were linked to better pain relief at 6 months. By identifying these predictors, doctors may be able to choose the right patients for this treatment and avoid unnecessary procedures.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
corticosteroid (steroid) injection
What this could lead to
If successful, this could help doctors better predict which patients with neck and arm pain will benefit from steroid injections, reducing unnecessary procedures.
What could go wrong
This is a small, retrospective study that only looks back at past data. It cannot prove cause and effect, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

107 people

The number who actually took part.

Started

Jan 2018

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of adult patients with cervical radiculopathy related to cervical disc herniation who underwent interlaminar cervical epidural steroid injection at the Mersin University Faculty of Medicine, Pain Clinic between January 1, 2018, and October 1, 2025. Only patients who met the predefined inclusion and exclusion criteria and had available pre-procedural, procedural, and post-procedural follow-up data, including Numeric Rating Scale (NRS-11) pain scores, were included in the analysis.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years. * Presence of neck and upper extremity pain consistent with cervical radiculopathy * Persistence of symptoms for at least 1 month despite conservative treatment * Documented baseline NRS-11 pain score prior to the procedure and follow-up NRS-11 data available through at least 6 months after treatment. Exclusion Criteria: * Active infection during the time of injection * Allergie to local anesthetics or contrast agents * History of bleeding diathesis. * Insufficient follow-up data (less than 6 months of follow-up NRS-11 documentation).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Disc disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lumbar disk degenerative disorder Neck Pain radiculopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Disc disease Neck pain Radicular pain Radiculopathy, cervical region

Contacts and locations

Locations

  • Department of Pain Medicine, Mersin University Faculty of Medicine

    Mersin, Ciftlikkoy, 33110, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.